Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
230.87
-1.64 (-0.71%)
At close: Aug 3, 2026, 4:00 PM EDT
228.58
-2.29 (-0.99%)
After-hours: Aug 3, 2026, 5:17 PM EDT

CRL Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-182.84-142.1625.29480.37492.61398.84
Depreciation & Amortization
350.1403.31361.74314.12303.87265.54
Stock-Based Compensation
80.3371.0869.8972.0573.6271.47
Other Adjustments
287.73391.33307.98-80.26-97.9-17.99
Change in Receivables
-0.2335.7421.61-33.43-150.57-26.63
Changes in Inventories
-0.89-48.7816.8-62.3-78.52-25.16
Changes in Accounts Payable
-1.932.87-14.27-20.43-2.6544.9
Changes in Accrued Expenses
-19.7179.31-27.612.45-42.1644.3
Changes in Unearned Revenue
-26.38-23.4925.13-37.3188.123.52
Changes in Other Operating Activities
-44.15-31.57-5238.6433.242.01
Operating Cash Flow
607.03737.65734.58683.9619.64760.8
Operating Cash Flow Growth
-21.81%0.42%7.41%10.37%-18.55%39.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-215.74-219.15-232.97-318.53-324.73-228.77
Purchases of Investments
-23.27-20.08-52.88-54.22-158.27-45.56
Proceeds from Sale of Investments
10.429.141.696.674.556.53
Cash Acquisitions
-405.01--5.48-194.79-283.39-1,293
Proceeds from Business Divestments
60.117.44--163.28122.69
Other Investing Activities
1.83.364.55-2.29-9.350.26
Investing Cash Flow
-571.69-209.32-245.09-563.16-607.92-1,438

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
1,7241,2281,082776.352,9526,951
Long-Term Debt Repaid
-1,556-1,349-1,494-851.68-2,933-6,243
Net Long-Term Debt Issued (Repaid)
168.06-121.78-412.19-75.3219.79708.24
Issuance of Common Stock
1.940.7123.8825.625.1145.65
Repurchase of Common Stock
-215.83-360.67-119.18-24.16-38.65-40.71
Net Common Stock Issued (Repurchased)
-213.89-359.96-95.31.44-13.544.95
Other Financing Activities
-16.02-54.98-43.44-11.64-48.65-40.58
Financing Cash Flow
-83.68-536.73-550.93-85.52-42.4672.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
14.8118.83-17.478.0425.5817.73
Net Cash Flow
-33.5310.43-78.9143.27-5.113.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
391.29518.49501.61365.37294.91532.03
Free Cash Flow Growth
-30.53%3.37%37.29%23.89%-44.57%40.00%
FCF Margin
9.72%12.91%12.39%8.85%7.42%15.03%
Free Cash Flow Per Share
8.1210.459.767.145.7510.35
Levered Free Cash Flow
24.71-103.62-313.15325.95483.171,206
Unlevered Free Cash Flow
119.11198.45138.58436.75491.89595.74
SEC Filings: 10-K · 10-Q